Evidently has raised $15.0M in total across 1 funding round.
Evidently's investors include Clear Ventures, Engineering Capital, Framework Venture Partners, Khosla Ventures, Prosperity7 Ventures.
Evidently is a healthcare technology company that builds an AI platform for clinical data intelligence, automating documentation, research, and population health tasks to reduce clinician burnout and improve care quality.[1][2][3][6] It serves healthcare providers, clinicians, data abstractors, research teams, and care coordinators by integrating into existing EHR systems via SMART on FHIR, synthesizing structured and unstructured data (like labs, notes, faxes) into actionable summaries and real-time decision support.[1][2][6] The platform solves key problems such as unmanageable patient data volumes, documentation errors, missed reimbursements, and provider burden, with recent momentum including a $15 million Series A funding round in December 2024 and executive hires like Head of Marketing Andrés to fuel growth.[1]
Evidently was founded in 2020 in Palo Alto, California, by Feng Niu (CEO) and Jaeho (co-founder, machine learning expertise from Apple and Stanford), amid rising demands for AI to handle complex healthcare data.[1][3] The idea emerged from recognizing healthcare's data overload—disparate sources like EHRs and faxes bogging down clinicians—leading to a "cognitive AI resident" that pre-reads charts for summaries and insights.[2][6] Early traction built on this by automating clinical summarization and decision support, culminating in the 2024 Series A funding and additions like Chief Product Officer Kalie Dove-Maguire (November 2023), positioning it for scaled adoption.[1][3]
(Note: Distinct from Evidently AI at evidentlyai.com, an open-source ML monitoring tool.[4][7])
Evidently rides the AI-in-healthcare wave, capitalizing on post-2023 generative AI advances to tackle documentation burdens amid clinician shortages and rising administrative costs.[1][6] Timing is ideal: U.S. healthcare faces $265B+ annual burnout-related losses, while regulations like FHIR standards enable plug-and-play AI; market forces like reimbursement pressures and value-based care favor tools uncovering "missed opportunities."[1] It influences the ecosystem by setting benchmarks for ethical, workflow-native AI, partnering with leading organizations to elevate care standards and provider wellbeing, potentially accelerating AI adoption in nuanced sectors like population health.[3][6]
Evidently's trajectory points to rapid expansion post-Series A, with hires signaling aggressive scaling into more EHRs, research, and revenue optimization amid AI healthcare funding surges.[1] Trends like multimodal AI and regulatory tailwinds (e.g., FDA AI guidance) will shape it, potentially evolving from "AI resident" to full enterprise platform influencing documentation integrity at scale. As CEO Feng Niu notes, it addresses "intrinsic financial, clinical challenges"—watch for partnerships and metrics on ROI as it redefines clinician empowerment.[1] This positions Evidently as a core player in turning data mountains into patient wins.
Evidently has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in December 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2024 | $15.0M Series A | Clear Ventures, Engineering Capital, Framework Venture Partners, Khosla Ventures, Prosperity7 Ventures |
